Larifāns produces medical products and cosmetics based on the pharmaceutically active substance dsRNA Larifan.
This unique, active substance was developed at Latvia’s Institute of Microbiology in the 1980s. Commercial products based on dsRNS Larifan have been made since 1994. Larifan is an immunomodulator, interferon inducer of natural origin with a broad spectrum of action. Larifan is used in fields including immunology, virology and oncology.
Larifan is widely used as antiviral and immunomodulating agent in different viral diseases causing herpes, influenza, encephalitis, hepatitis, papilloma (warts) and different sexually transmissible diseases. In gynaecology, Larifan is widely used for the treatment of cervical dysplasia. Larifan is also used for the correction of secondary immunodeficiency and in oncology as a component of biotherapeutic courses of treatment.
We are interested in cooperation with pharmaceutical and medical companies, with pharmacies, clinics and hospitals who are interested in the distribution of Larifan.
